These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11755462)

  • 1. Multidrug resistance (MDR-1) expression in AIDS-related lymphomas.
    Tulpule A; Sherrod A; Dharmapala D; Young LL; Espina BM; Sanchez MN; Gill PS; Levine AM
    Leuk Res; 2002 Feb; 26(2):121-7. PubMed ID: 11755462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein expression in non-Hodgkin's lymphomas of human immunodeficiency virus infected patients.
    Tanaka PY; Calore EE
    Pathol Res Pract; 2007; 203(1):1-7. PubMed ID: 17157997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
    Levine AM; Tulpule A; Espina B; Sherrod A; Boswell WD; Lieberman RD; Nathwani BN; Welles L
    J Clin Oncol; 2004 Jul; 22(13):2662-70. PubMed ID: 15226333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol.
    Schürmann D; Grünewald T; Weiss R; Jautzke G; Pohle HD; Ruf B
    Eur J Haematol; 1995 Feb; 54(2):73-7. PubMed ID: 7535244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program.
    Sawka CA; Shepherd FA; Brandwein J; Burkes RL; Sutton DM; Warner E
    Leuk Lymphoma; 1992 Oct; 8(3):213-20. PubMed ID: 1283356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance in AIDS-related lymphoma.
    Tulpule A
    Curr Opin Oncol; 2005 Sep; 17(5):466-8. PubMed ID: 16093797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection.
    Taillan B; Garnier G; Ferrari E; Pesce A; Vinti H; Fuzibet JG; Dujardin P
    Acta Haematol; 1993; 89(1):10-2. PubMed ID: 7683165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for previously untreated patients with AIDS-associated non-Hodgkin's lymphoma.
    Martí-Carvajal AJ; Cardona AF; Lawrence A
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005419. PubMed ID: 19588373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS-related systemic non-Hodgkin's lymphoma at a large community program.
    Vilchez RA; Kozinetz CA; Jorgensen JL; Kroll MH; Butel JS
    AIDS Res Hum Retroviruses; 2002 Mar; 18(4):237-42. PubMed ID: 11860669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
    Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS
    Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay.
    Zhan Z; Sandor VA; Gamelin E; Regis J; Dickstein B; Wilson W; Fojo AT; Bates SE
    Blood; 1997 May; 89(10):3795-800. PubMed ID: 9160686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
    Gisselbrecht C; Oksenhendler E; Tirelli U; Lepage E; Gabarre J; Farcet JP; Gastaldi R; Coiffier B; Thyss A; Raphael M
    Am J Med; 1993 Aug; 95(2):188-96. PubMed ID: 7689296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
    Kaplan LD; Shiramizu B; Herndier B; Hahn J; Meeker TC; Ng V; Volberding PA; McGrath MS
    Blood; 1995 Apr; 85(7):1727-35. PubMed ID: 7535586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
    Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
    Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.
    Straus DJ; Huang J; Testa MA; Levine AM; Kaplan LD
    J Clin Oncol; 1998 Nov; 16(11):3601-6. PubMed ID: 9817281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
    Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
    Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
    Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone.
    Navarro JT; Ribera JM; Oriol A; Vaquero M; Romeu J; Batlle M; Flores A; Millá F; Feliu E
    Br J Haematol; 2001 Mar; 112(4):909-15. PubMed ID: 11298585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
    Filipits M; Jaeger U; Simonitsch I; Chizzali-Bonfadin C; Heinzl H; Pirker R
    Clin Cancer Res; 2000 Sep; 6(9):3417-23. PubMed ID: 10999723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.
    Wilson WH; Bates SE; Fojo A; Bryant G; Zhan Z; Regis J; Wittes RE; Jaffe ES; Steinberg SM; Herdt J
    J Clin Oncol; 1995 Aug; 13(8):1995-2004. PubMed ID: 7636540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.